Kenvue

NYSE: KVUE

Stock price

18.98 USD

(+Infinity%) NaN day

Financial Performance

Share

5Y price score: (40)

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: (29.4)%

DATE RANGE:

US$ Per
Share

By default your notes are visible only to you.

14.0

52-week range

22.8

18.98

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

5 %

Dividend Yield TTM

4.4 %

Market cap $

$ 36,442

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

22.3

Price / Book TTM

3.4

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

0.5

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

(9.4) %

(21.9) %

(29.4) %

Free cash flow per share growth

28.9 %

(46.6) %

-

Earnings per share growth

40.7 %

261.7 %

-

Founded: 2,022

Employees: 22,000

Business Summary:Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Fair Value Reference Estimate

Latest Earnings Call Takeaways

Annual Reports, Presentations And IR Contacts

Go to the website

Kenvue — Financial Overview, Stock Price, Market Cap

Kenvue is a company. Founded in 2022. As of July 20, 2026, the company's market capitalization is $36441764519 with a current stock price of $18.98.